Trial Profile
A Multicenter, Open Label Study to Evaluate the Safety and Efficacy of Tigecycline to Treat Complicated Skin and Skin Structure Infections (cSSSI) in Hospitalized Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2008
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 27 Dec 2007 Status change from recruiting to completed.
- 18 Jul 2007 New trial record.